EUCAST News
Here you can find the latest news and updates from EUCAST.
EUCAST clinical trial of blood culture RAST in 55 laboratories published.
Following the initial development,published in 2019, a clinical trial in 55 laboratories was performed andpublished in 2020. [more]
Ceftazidime-avibactam rationale document published
Ceftazidime-avibactam RD available.[more]
Interpretation of breakpoints for antifungal agents when definitions of S, I and R have changed - publication in CMI.
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST).Arendrup et al.Clin Microbiol...[more]
Public consultation on piperacillin-tazobactam breakpoints and meningitis breakpoints.
There are proposed changes to piperacillin-tazobactam breakpoints for Enterobacterales. There are proposed breakpoints for bacterial meningitis. Both are now open for general consultation 17 July - 15 September, 2020.[more]
Oral cephalosporins and Enterobacterales breakpoints - updated guidance document.
Oral cephalosporins and Enterobacterales breakpoints - updated guidance document. [more]
SOP 9 revised (9.2) and SOP 11.0 published.
SOP 9 (on determining disk diffusion breakpoints and QC criteria) and SOP 11.0 (on determining the disk content/potency). [more]
